Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC2185
TNBC
Luminal
PD 98059
MEK
MAPK
12192.159
uM
1.4270
999.99990
0.1594 -0.6247 0.1237 0.4211
0.6547
0.8215
HCC2185
TNBC
Luminal
PD173074
FGFR1/3
RTK
7462.093
uM
26.43830
32.46810
-0.0083 -0.8967 5.0000 0.0841
0.9360
0.4426
HCC2185
TNBC
Luminal
PD184352
MEK
MAPK
10996.155
uM
inf
inf
0.8210 0.8210 0.0000 0.1837
0.0000
0.6934
HCC2185
TNBC
Luminal
PD184352
MEK
MAPK
10996.155
uM
inf
inf
0.8210 0.8210 0.0000 0.1837
0.0000
0.6934
HCC2185
TNBC
Luminal
PD184352
MEK
MAPK
12192.155
uM
inf
inf
0.7159 0.7159 0.0000 0.2130
0.0390
0.7451
HCC2185
TNBC
Luminal
PD184352
MEK
MAPK
12192.155
uM
inf
inf
0.7159 0.7159 0.0000 0.2130
0.0390
0.7451
HCC2185
TNBC
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7464.095
uM
inf
inf
0.9059 0.9059 0.0000 -0.0281
-0.2886
0.5464
HCC2185
TNBC
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7462.095
uM
inf
inf
0.6298 0.6298 0.0000 0.0764
0.3441
0.3840
HCC2185
TNBC
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7463.094
uM
inf
inf
0.9058 0.9058 0.0000 0.0673
0.4936
0.6482
HCC2185
TNBC
Luminal
PS-1145
IKK
NFKB
7464.065
uM
inf
inf
0.9611 0.9611 0.0000 -0.0098
-0.0695
0.7107
HCC2185
TNBC
Luminal
PS-1145
IKK
NFKB
7463.065
uM
inf
35.55020
0.7381 0.7589 4.9874 0.0873
0.7220
0.5226
HCC2185
TNBC
Luminal
PS-1145
IKK
NFKB
7462.065
uM
inf
12.12690
0.5787 0.6650 4.9993 0.1530
0.7936
0.3950
HCC2185
TNBC
Luminal
Purvalanol A
CDK1
CDK
7462.067
uM
inf
inf
0.9338 0.9338 0.0000 -0.0238
-0.3817
0.4873
HCC2185
TNBC
Luminal
Purvalanol A
CDK1
CDK
7463.067
uM
32.99550
17.88630
0.3072 0.2671 1.2477 0.1630
0.9290
0.6688
HCC2185
TNBC
Luminal
Purvalanol A
CDK1
CDK
7464.067
uM
17.06480
19.38990
-0.3169 -0.3172 3.8462 0.2049
0.9955
0.7308
HCC2185
TNBC
Luminal
QNZ
NFkB
NFKB
7462.096
uM
0.00116
0.00255
-0.6368 -0.6418 1.0495 1.2048
0.9957
0.3514
HCC2185
TNBC
Luminal
Ribavirin
15306.211
uM
inf
inf
0.9179 0.9179 0.0000 0.0789
0.0000
0.4935
HCC2185
TNBC
Luminal
SB-3CT
MMP2/9
MMP
10996.144
uM
inf
inf
0.4725 0.4725 0.0000 0.1714
0.4081
0.5116
HCC2185
TNBC
Luminal
SB-3CT
MMP2/9
MMP
12192.144
uM
inf
inf
0.2245 0.2245 0.0000 0.2059
0.5237
0.5798
HCC2185
TNBC
Luminal
Selumetinib
MEK
MAPK
12192.155
uM
inf
inf
0.8352 0.8352 0.0000 0.1087
-0.0684
0.7451
HCC2185
TNBC
Luminal
Selumetinib
MEK
MAPK
10996.155
uM
inf
inf
0.9728 0.9728 0.0000 0.0875
0.0658
0.6934
HCC2185
TNBC
Luminal
Sigma A6730
AKT
AKT
10996.153
uM
0.80696
1.86130
-0.9987 -0.9947 1.3103 0.6148
0.9761
0.3186
HCC2185
TNBC
Luminal
Sigma A6730
AKT
AKT
12192.158
uM
2.37830
7.77320
-0.7569 -1.0000 0.9276 0.3892
0.9796
0.6680
HCC2185
TNBC
Luminal
Sirolimus
MTOR
MTOR
7463.068
uM
0.00019
0.00017
-0.0655 0.0169 0.3266 0.8520
0.8086
0.5887
HCC2185
TNBC
Luminal
Sirolimus
MTOR
MTOR
7845.068
uM
0.00087
0.00157
-0.5451 -0.3982 0.9850 1.2168
0.9289
0.3849